
Metabolites, Journal Year: 2025, Volume and Issue: 15(3), P. 195 - 195
Published: March 11, 2025
Background/Objectives: Ceramide, a sphingolipid metabolite, has emerged as key player in various physiological and pathological processes. Changes ceramide levels are associated with the occurrence development of diseases, highlighting its potential biomarker clinical diseases. Methods: The biosynthesis metabolism discussed, along functions cell signaling, apoptosis, inflammation. This study further examines for disease diagnosis treatment. Results: article highlights involvement several including cardiovascular dermatosis, cancer, neurodegenerative disorders metabolic syndromes. For each disease, prognosis is explored, feasibility therapeutic strategies targeting reviewed. Additionally, challenges future directions field research addressed. Conclusions: review provides an overview recent advances understanding role diseases diagnostic tool.
Language: Английский